Diprivan is a medicine containing the active ingredient(s) propofol. On this page you will find out more about Diprivan, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: propofol
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Diprivan 500 mg/50 mL injection emulsion, 50 mL syringe
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Diprivan is a short-acting intravenous anaesthetic agent suitable for induction and maintenance of general anaethesia in adults and in children aged three years and older. Diprivan has no analgesic properties. Although the safety and efficacy of Diprivan in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. Diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. Diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures. INDICATIONS AS AT 4 NOVEMBER 2004: Induction of General Anaesthesia in Children and Adults. DIPRIVAN is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older. Maintenance of General Anaesthesia in Children and Adults. DIPRIVAN is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older. DIPRIVAN may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided. DIPRIVAN has no analgesic properties. Sedation During Intensive Care in Adults. DIPRIVAN may also be used in adults for sedation of ventilated patients receiving intensive care. Conscious Sedation for Surgical and diagnostic Procedures in Adults. DIPRIVAN may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.
Table of characteristics
|Visual appearance||A white or almost white, homogenous emulsion, practically free from extraneous particulate contamination and large oil droplets. Slight creaming may be visible on prolonged standing.|
|Dosage Form||Injection, emulsion|
|Route of administration||Intravenous|
1 x 50mL syringe: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store between 2 - 25 degrees celsius|
|Storage conditions||Do not Freeze|
|Life time||2 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.